Close Menu

John Hussman is not a scientist — he's a fund manager. The former economics professor runs the $6 billion Hussman Strategic Growth Fund, where he has a reputation for thoroughly researching potential investments and analyzing the markets, says Fortune's Scott Cendrowski. Now, Hussman is applying his research skills to understanding autism. Ever since his son was diagnosed with the disorder as a child, Hussman has focused his attention on finding its genetic causes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.